PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
PPARγ and PPARδ agonists represent unique classes of drugs that act through their ability to modulate gene transcription associated with intermediary metabolism, differentiation, tumor suppression, and in some instances proliferation and cell adhesion. PPARγ agonists are used by millions of people e...
Saved in:
Main Authors: | Robert I. Glazer, Hongyan Yuan, Zhihui Xie, Yuzhi Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/247379 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPAR-δ in Vascular Pathophysiology
by: Nanping Wang
Published: (2008-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS
by: Zhigang Zhao, et al.
Published: (2011-01-01) -
The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01) -
PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
by: Wojciech G. Garbacz, et al.
Published: (2015-01-01)